Invention Grant
- Patent Title: Glycosylated modified flavin adenine dinucleotide-dependent glucose dehydrogenases, compositions thereof as well as methods of making and using the same
-
Application No.: US14527887Application Date: 2014-10-30
-
Publication No.: US09637774B2Publication Date: 2017-05-02
- Inventor: Hartmut Duefel , Thomas Meier , Michael Tacke
- Applicant: Roche Diabetes Care, Inc.
- Applicant Address: US IN Indianapolis
- Assignee: Roche Diabetes Care, Inc.
- Current Assignee: Roche Diabetes Care, Inc.
- Current Assignee Address: US IN Indianapolis
- Priority: EP12166703 20120503
- Main IPC: C12Q1/54
- IPC: C12Q1/54 ; C12N9/00 ; C12N9/04

Abstract:
Compositions, devices, kits and methods are disclosed for assaying glucose with a glycosylated, modified flavin adenine dinucleotide-dependent glucose dehydrogenase (FAD-GDH), variant thereof or an active fragment thereof, where at least one asparagine residue at positions N2, N168 and N346 of mature, wild-type A. oryzae FAD-GDH according to SEQ ID NO:2 is substituted by one or more amino acids not suitable for glycosylation, thereby eliminating or inactivating, respectively, a potential glycosylation site at this position.
Public/Granted literature
Information query